Genome Valley Biotech Parks And Incubators Profile
Key Indicators
- Authorised Capital ₹ 5.10 Cr
as on 06-11-2024
- Paid Up Capital ₹ 5.01 Cr
as on 06-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 70.91 Cr
as on 06-11-2024
- Satisfied Charges ₹ 0.10 M
as on 06-11-2024
- Revenue 77.24%
(FY 2023)
- Profit 124.32%
(FY 2023)
- Ebitda 73.75%
(FY 2023)
- Net Worth 129.85%
(FY 2023)
- Total Assets 331.33%
(FY 2023)
About Genome Valley Biotech Parks And Incubators
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.10 Cr and a paid-up capital of Rs 5.01 Cr.
The company currently has active open charges totaling ₹70.91 Cr. The company has closed loans amounting to ₹0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Veena Solipuram, Vishal Goel, Prabhaker Solipuram, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TG2021PTC147819
- Company No.
147819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2021
- Date of AGM
10 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Genome Valley Biotech Parks And Incubators?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milind Ravi  | Director | 09-Nov-2021 | Current |
Veena Solipuram  | Director | 04-Jul-2023 | Current |
| Vishal Goel | Director | 11-Feb-2021 | Current |
| Prabhaker Solipuram | Director | 09-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Genome Valley Biotech Parks And Incubators.
Genome Valley Biotech Parks And Incubators Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 77.24% increase. The company also saw a substantial improvement in profitability, with a 124.32% increase in profit. The company's net worth Soared by an impressive increase of 129.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genome Valley Biotech Parks And Incubators?
In 2023, Genome Valley Biotech Parks And Incubators had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sln Terminus Hotels & Resorts Private LimitedActive 10 years 7 monthsPrabhaker Solipuram is a mutual person
Crimson Education Management Services Private LimitedActive 4 years 11 monthsVishal Goel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2023 | ₹70.00 Cr | Open |
Others Creation Date: 27 Jul 2021 | ₹9.10 M | Open |
Others Creation Date: 24 Jul 2021 | ₹0.10 M | Satisfied |
How Many Employees Work at Genome Valley Biotech Parks And Incubators?
Genome Valley Biotech Parks And Incubators has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genome Valley Biotech Parks And Incubators, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome Valley Biotech Parks And Incubators's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
